Investigation of the Serum Levels of TGF-β and IL-6 Cytokines Effective on the Immune System of Diabetic Patients with Toxoplasma Parasitic Infection: A Short Report
-
Published:2024-07-01
Issue:3
Volume:23
Page:164-172
-
ISSN:1010-6405
-
Container-title:Journal of Rafsanjan University of Medical Sciences
-
language:fa
-
Short-container-title:JRUMS
Author:
Dabirzadeh MansourORCID,
Hossein Beigi RoghayehORCID,
Poursamimi JavadORCID,
Arab Yaghoobi Ladan
Publisher
Apex Publishing
Reference15 articles.
1. Tosur M, Geyer SM, Rodriguez H, Libman I, Baidal DA, Redondo MJ. Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk. Diabetologia 2018; 61(9): 2043-53.
2. Wondmkun YT. Obesity, insulin resistance, and type 2 diabetes: Associations and therapeutic implications. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020; 13: 3611-16.
3. Mensah-Brown EPK, Shahin A, Al-Shamisi M, Wei X, Lukic ML. IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin. Eur J Immunol 2006; 36(1): 216–23.
4. Oliveira-Scussel AC de M, Ferreira PTM, Resende R de S, Ratkevicius-Andrade CM, Gomes A de O, Paschoini MC, et al. Association of gestational diabetes mellitus and negative modulation of the specific humoral and cellular immune response against Toxoplasma gondii. Front Immunol 2022; 13(10.3389): 1–18.
5. Matowicka-Karna J, Dymicka-Piekarska V KH. Does Toxoplasma gondii infection affect the levels of IgE and cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)? Clin Dev Immunol 2009; 2009, 1–4.